Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 30:10:946219.
doi: 10.3389/fcell.2022.946219. eCollection 2022.

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis

Affiliations
Review

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis

Ganggang Zhai et al. Front Cell Dev Biol. .

Abstract

Osteoarthritis (OA) is the most common joint disease, usually occurring in middle-aged and elderly people. However, current treatment for OA in its early stages is ineffective, and drug therapy is often ineffective in slowing the progression of the disease. In fact, a deeper understanding of the underlying molecular mechanisms of OA could help us to better develop effective therapeutic measures. N6-methyladenosine (m6A) is a methylation that occurs at the adenosine N6-position, which is the most common internal modification on eukaryotic mRNAs. The role and mechanisms of m6A in mammalian gene regulation have been extensively studied. The "Writer", "eraser", and "reader" proteins are key proteins involved in the dynamic regulation of m6A modifications. Recent studies on post-transcriptional regulation alone have shown that m6a modification has an important role in the development of OA. This paper summarizes the specific regulatory processes of M6A in disease and reviews the role of m6A in OA, describing its pathophysiological role and molecular mechanisms, as well as its future research trends and potential clinical applications in OA.

Keywords: N6-methyladenosine; biomarker; molecular mechanisms; osteoarthritis; therapeutic target.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer QD declared a shared affiliation with the author ZL to the handling editor at the time of review.

Figures

FIGURE 1
FIGURE 1
RNA methylation modification process. Writers, erasers and readers add, remove and identify methyl groups respectively. This process makes the m6A modification flexible and reversible.
FIGURE 2
FIGURE 2
m6A modification in bone development. M6a modification regulates osteoblast differentiation by regulating MBP2 gene expression and the PTH/Pth1r signaling axis. In addition, m6a modification also promotes the process of bone resorption by regulating the expression of RANK gene.
FIGURE 3
FIGURE 3
Molecular mechanisms of m6a modifications in the pathogenesis of OA. M6A modification ultimately cause cartilage apoptosis, cellular senescence, increased inflammatory response and extracellular matrix imbalance through regulation of gene expression and signaling pathways.

Similar articles

Cited by

References

    1. Chen D., Shen J., Zhao W., Wang T., Han L., Hamilton J. L., et al. (2017). Osteoarthritis: toward a Comprehensive Understanding of Pathological Mechanism. Bone Res. 5, 16044. 10.1038/boneres.2016.44 - DOI - PMC - PubMed
    1. Chen J., Tian Y., Zhang Q., Ren D., Zhang Q., Yan X., et al. (2021). Novel Insights into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology. Stem Cells Dev. 30 (1), 17–28. 10.1089/scd.2020.0157 - DOI - PubMed
    1. Chen P. B., Shi G. X., Liu T., Li B., Jiang S. D., Zheng X. F., et al. (2022a). Oxidative Stress Aggravates Apoptosis of Nucleus Pulposus Cells through m6A Modification of MAT2A Pre-mRNA by METTL16. Oxid. Med. Cell Longev. 2022, 4036274. 10.1155/2022/4036274 - DOI - PMC - PubMed
    1. Chen X., Gong W., Shao X., Shi T., Zhang L., Dong J., et al. (2022b). METTL3-mediated m6A Modification of ATG7 Regulates Autophagy-GATA4 axis to Promote Cellular Senescence and Osteoarthritis Progression. Ann. Rheum. Dis. 81 (1), 87–99. 10.1136/annrheumdis-2021-221091 - DOI - PubMed
    1. Chen Y., Peng C., Chen J., Chen D., Yang B., He B., et al. (2019). WTAP Facilitates Progression of Hepatocellular Carcinoma via m6A-HuR-dependent Epigenetic Silencing of ETS1. Mol. Cancer 18 (1), 127. 10.1186/s12943-019-1053-8 - DOI - PMC - PubMed

LinkOut - more resources